Skip to content

Correlation between chemotherapy toxicity and body composition in early breast cancer: a prospective, observational cohort study based on DXA

Correlation between chemotherapy toxicity and body composition in early breast cancer: a prospective, observational cohort study based on DXA

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600129082
Enrollment
Unknown
Registered
2026-07-30
Start date
2025-07-23
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Toxicity management of chemotherapy for breast cancer

Interventions

Sponsors

The First Affiliated Hospital of Jinzhou Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
18 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Women aged >= 18 years old; 2. Stage I - ? invasive breast cancer; 3. Complete clinical pathological data; 4. Patients receiving neoadjuvant or adjuvant chemotherapy; 5. We plan to accept chemotherapy regimens containing anthracyclines and/or taxanes, including one week regimens, intensive regimens, and three week regimens.

Exclusion criteria

Exclusion criteria: 1. Have a history of malignant tumors in the past; 2. Diseases previously treated with cytotoxic drugs (such as rheumatic and autoimmune diseases); 3. Any physical condition that hinders participation in the research process (such as inability to cooperate with examinations, etc.); 4. Pregnant women.

Design outcomes

Primary

MeasureTime frame
Neutropenia;

Secondary

MeasureTime frame
Nausea and vomiting;alopecia;

Countries

China

Contacts

Public ContactTang Xiaotong

The First Affiliated Hospital of Jinzhou Medical University

tangxiaotong0824@163.com+86 199 6125 0137

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Aug 10, 2026